The North American COVID-19 diagnostics industry will see the considerable decline of 24.7% during the forecast period. North America is anticipated to make huge contribution to the global COVID-19 diagnostics market in 2020; however, the market will decline during the forecast period. In the US, CDC is collaborating with commercial laboratories to perform and publish results from a large-scale geographic seroprevalence survey that has tested de-identified clinical blood specimens from Connecticut, Louisiana, Minnesota, Missouri, New York City, Philadelphia, San Francisco, South Florida, Utah and Western Washington State for SARS-CoV-2 antibodies. The US conducted studies in 10 sites from March 23, 2020, to May 12, 2020, which aimed to test nearly 1,800 samples collected from each of these 10 areas, nearly every 3–4 weeks. As per the results of the data from CDC partnership with commercial laboratories to test de-identified clinical blood specimens for antibodies in Connecticut, South Florida, the New York City area, Missouri, Utah, and western Washington state, it was found that SARS-CoV-2 infections may be 10 times higher than the reported number of cases.
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/north-american-covid-19-diagnostics-market
In April 2020, the US National Institutes of Health (NIH) announced a $1.5 billion initiative to speed breakthroughs in diagnostic tests for COVID-19. The program aims to increase the US capacity for SARS-CoV-2 testing. The Ontario COVID-19 Rapid Research Fund is offering colleges, universities, research institutes and academic hospitals with funding to contribute to global efforts to contain the COVID-19 pandemic by making research related to new diagnostics procedure. Abbott Laboratories Inc., Adt Biotech Sdn Bhd, Beckman Coulter Inc., and Cellex Inc. are some of the key players operating in the region. The considerable presence of major market players in the region is further anticipated to propel the market growth.
Key questions addressed by the report
- What is the market growth rate during the forecast period?
- Which segment/region dominates the market in base year?
- Which segment/region will project fastest growth in the market during the forecast period?
- How COVID-19 will impact the market growth in 2020 and coming years?
o Recovery Timeline
o Deviation from pre-COVID-19
o Most affected region/segment
o Recommendations
- Who is the leader in the market?
- How players are addressing challenges to sustain growth?
- Where is the investment opportunity?
North American COVID-19 Diagnostics Market – Segmentation
By Type
- Instruments
- Reagents & Kits
- Laboratory Testing Services
By Technology Type
- PCR Test
- Antigen Test
o Chromatographic Immunoassay
o Fluorescent Immunoassay
o Chemiluminescent Immunoassay
- Serology Test
o Enzyme-Linked Immunosorbent Assay (ELISA)
o Neutralization
o Chemiluminescent Immunoassay
- Rapid/ PoC Test
By Sample Type
- Oropharyngeal & Nasopharyngeal Swabs
- Blood
- Urine
- Saliva
- Others (Sperm)
By End-Users
- Laboratories
- Hospitals
- Diagnostic Centers & Clinics
- Research Institutes
A full report of North American COVID-19 Diagnostics Market is available at: https://www.omrglobal.com/industry-reports/north-american-covid-19-diagnostics-market
North American COVID-19 Diagnostics Market– Segment by Region
North America
- United States
- Canada
Company Profiles
- Abbott Laboratories Inc.
- Beckman Coulter, Inc.
- Cellex Inc.
- Cepheid Inc.
- Chembio Diagnostics Systems Inc.
- Epitope Diagnostics, Inc.
- Hologic Inc.
- Laboratory Corp. of America Holdings
- Luminex Corp.
- PerkinElmer, Inc.
- Quidel Corp.
- Thermo Fisher Scientific, Inc.
Reasons to Buying From us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
